AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Ascendis Pharma A/S

$251.27 +$37.98 (+17.81%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$253.00
Day Range
$249.55$255.61
Year Range
$188.07$282.15
Market Cap
16.53B
AVG Volume
724.75K
Trailing/Forward PE
18.57/27.6
PEG ratio
-0.03
Dividend Yield
-
Next Earnings Date
2026-11-11
Primary Exchange
NASDAQUS
Revenue (EUR) · TTM
0500M1B1.5B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ASND Revenue (EUR) by quarter, trailing twelve months
PeriodRevenue (EUR)
26 Q21.05B
26 Q1867.51M
25 Q4717.81M
25 Q3646.55M
25 Q2490.75M
25 Q1368.7M
24 Q4363.64M
24 Q3327.43M
24 Q2317.63M
24 Q1329.02M
Net Income (EUR) · TTM
-1B-500M0500M1B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ASND Net Income (EUR) by quarter, trailing twelve months
PeriodNet Income (EUR)
26 Q2755.85M
26 Q1506.6M
25 Q4-227.72M
25 Q3-232.94M
25 Q2-271.15M
25 Q1-341.67M
24 Q4-378.08M
24 Q3-426.49M
24 Q2-489.52M
24 Q1-501.57M
Operating Income (EUR) · TTM
-400M-200M0200M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ASND Operating Income (EUR) by quarter, trailing twelve months
PeriodOperating Income (EUR)
26 Q2109.45M
26 Q1-6.93M
25 Q4-136.36M
25 Q3-145.78M
25 Q2-253.52M
25 Q1-333.83M
24 Q4-278.76M
24 Q3-315.76M
24 Q2-353.42M
24 Q1-361M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (EUR) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: ASND

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 11 Nov 2026.

Ascendis Pharma A/S
ASND
Stockpicker

Video analysis: ASND

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: ASND

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.